CMS finalizes Medicare Advantage and Part D Payment Policies
CMS issued a final rule April 1 to update 2020 payment policies for Medicare Advantage and Part D prescription drug plans.
CMS issued a final rule April 1 to update 2020 payment policies for Medicare Advantage and Part D prescription drug plans.
Opioid use among Blue Shield of California members with noncancer pain fell 56 percent since 2014, the health insurer said March 18.
In an effort to reduce prescription drug costs in the last year, nearly one in every five patients asked their physician for a lower-cost medication, according to a new report from the CDC.
Almost half — 46 percent — of adults aren't familiar with "Medicare for All" proposals, according to a survey from NORC at the University of Chicago.
Sixty-four percent of consumers reported that they would jump on an opportunity to prepay for medications to receive a discounted price, according to a survey from DrFirst, a provider of e-prescribing and patient medication management solutions.
Almost half — 46 percent — of adults aren't familiar with "Medicare for All" proposals, according to a survey from NORC at the University of Chicago.
Price hikes on existing drugs and new medications coming to market are the primary contributors to rising prescription drug prices, a new study published in Health Affairs reveals.
CMS issued a proposed rule Nov. 26 that would allow insurers to implement broader use of step therapies or drop coverage of certain protected classes of drugs if price increases outpace inflation. Below is a breakdown of the winners and losers under the proposed rule changes.
UnitedHealthcare introduced a new program Oct. 29 that incentivizes members to choose less expensive prescription drugs.
A recent investigation by the U.S. Office of Inspector General found between 2014 and 2016, Medicare Advantage organizations overturned 75 percent of their preauthorization and payment denials upon appeal.